Alteration of liver enzymes is a feature of the MYH9-related disease syndrome. - Wikidata - awgldk - TriplyDB

Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

http://www.wikidata.org/entity/Q33401062

about

Severe to profound deafness may be associated with MYH9-related disease: report of 4 patients Genetics of familial forms of thrombocytopenia.R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.Cochlear implantation is safe and effective in patients with MYH9-related disease.Diagnosis and treatment of inherited thrombocytopenias.Molecular basis of inherited thrombocytopenias.Myosin heavy chain-9-related disorders (MYH9-RD): a case report.Bleeding is not the main clinical issue in many patients with inherited thrombocytopaenias.Genetic susceptibility to idiopathic membranous nephropathy in high-prevalence Area, Taiwan MYH9 gene mutations associated with bleeding.Phenotype description and response to thrombopoietin receptor agonist in -related disorder

P2860

Q30364931-169ED4B2-8C31-4BC1-99A3-863C08E99B23 Q33402780-A8788FDE-D06D-41AB-94D6-AECE3D3066DB Q33415697-CC52A292-C74F-4460-9FF4-CC961E0B5EE0 Q33416191-1D49151D-EA82-4B3B-8A7B-12DE5F521430 Q33422383-988A1C95-4C6C-482B-B3B3-D325AD8CB742 Q33422658-B8A50224-9158-47BE-AB71-7556D293798B Q33423143-F09E0FFF-53EA-4C67-B9D4-4EEFC206B16B Q33442532-AA60E33C-93F2-44D2-984C-B105B2980661 Q34691828-528D6932-8237-421F-A6D1-3AD18AECFFFB Q52884676-B15344D3-3FB8-4229-81E7-3D643F35221C Q58717272-97D507EA-5B71-4DB3-A5EA-45F49F7795F6

P2860

Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

http://www.wikidata.org/entity/Q33401062

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

@ast

Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

@en

type

label

Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

@ast

Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

@en

prefLabel

Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

@ast

Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

@en

P1433

Q33401062-45FD145C-9E63-4A5D-AA51-D612EA195784

P1476

Q33401062-8BFA417F-AC15-4D17-B5AA-5EBBFD325DF4

P2093

Q33401062-03970AE7-345A-4BA2-A47B-E5271273403F

Q33401062-22BABBEA-0308-42B0-A792-8EDE803E5D5D

Q33401062-32D74451-DFC1-409B-AC00-CA044B4ED13C

Q33401062-4C0B5061-C012-42FA-9CD9-C3F4BEBADBED

Q33401062-700148F9-626C-41A3-B625-982BA97870A1

Q33401062-A7CBC656-44CD-4503-A2A2-5186E717FC48

Q33401062-AD32648C-A06F-4EDF-82F6-4B5062E82D50

Q33401062-C6EDDB5A-12AE-4828-8A1A-7361CCB388A4

Q33401062-F7296653-2762-4B31-BD97-1660F13D8E50

Q33401062-FEE161C1-B159-4CEC-A9C2-15BA1D962340

P2860

Q33401062-01632ACB-A181-4EC1-82FD-4DFEF0E54BAA

Q33401062-03B64740-1609-418E-8871-6438EBDFE034

Q33401062-03B90E9E-7382-4B3A-8744-75EE4B4EB4E7

Q33401062-153CECDD-5B29-4E16-8B02-4BD657D67DFC

Q33401062-25457B90-1D10-44C6-8A45-76B1EE84E40A

Q33401062-2ACF8D18-A116-45D7-B0CA-EC9206C6B5D2

Q33401062-2DD2AF51-465E-4D9A-846A-299FF63FA885

Q33401062-3984B60A-A013-4EAC-A784-55EBF5F4A877

Q33401062-3B5ADD46-429C-4947-B587-4638CC7A6154

Q33401062-52216D0B-465F-4A6C-A609-268E297DBD77

P304

Q33401062-BD214BF5-8F38-44AF-8AA7-85C8C4B44526

P31

Q33401062-2E13878E-6406-4720-AD33-C55F868570AD

P356

Q33401062-E8D8B127-4574-497A-BB10-FD47A21B848A

P407

Q33401062-5B7FB0BA-8C3D-489A-8367-A852F6368909

P433

Q33401062-2E52B6CE-BDEF-4750-A51E-8740F0AF4AD5

P478

Q33401062-7275C005-0D06-4812-BDA9-3D585134873D

P50

Q33401062-03E2C27B-325B-4404-9277-028774613F79

Q33401062-0ED4A519-A6B1-4C3A-B757-BC781C04EB8F

Q33401062-39341364-DEF0-401D-A0F3-11FD254D072E

Q33401062-959FA276-1F2D-45AA-9CD2-F65710173076

Q33401062-B2BE3E23-FDBE-4985-B27A-6A8734D18FE1

Q33401062-FCB6FC84-A5C1-4873-8221-0C58C1A7D485

P577

Q33401062-256B18B0-FC01-4583-8A08-E5B1128E4F50

P5875

Q33401062-FC7469A5-DE27-410F-B8BB-74720F95983C

P698

Q33401062-E5F8222D-C167-4E2C-B6EB-2C693DB8BED1

P932

Q33401062-A76A0734-C7A5-4521-82E3-37B075462D08

P356

JOURNAL.PONE.0035986

P1433

P1476

Alteration of liver enzymes is a feature of the MYH9-related disease syndrome

@en

P2093

Annamaria Mezzasoma

http://www.w3.org/2001/XMLSchema#string

Carlo Balduini

http://www.w3.org/2001/XMLSchema#string

Fabrizio Fabris

http://www.w3.org/2001/XMLSchema#string

Giuseppe Loffredo

http://www.w3.org/2001/XMLSchema#string

Italian Registry for MYH9-releated diseases

http://www.w3.org/2001/XMLSchema#string

Mario Pirastu

http://www.w3.org/2001/XMLSchema#string

Stefania Momi

http://www.w3.org/2001/XMLSchema#string

Tiziana Fierro

http://www.w3.org/2001/XMLSchema#string

Ugo Ramenghi

http://www.w3.org/2001/XMLSchema#string

Umberto Magrini

http://www.w3.org/2001/XMLSchema#string

P2860

A single class II myosin modulates T cell motility and stopping, but not synapse formation

Rho kinase, myosin-II, and p42/44 MAPK control extracellular matrix-mediated apical bile canalicular lumen morphogenesis in HepG2 cells.

Molecular determinants dictating cell surface expression of the human sodium-dependent vitamin C transporter-2 in human liver cells

Archival, demographic and genetic studies define a Sardinian sub-isolate as a suitable model for mapping complex traits.

Myosin II regulatory light chain is required for trafficking of bile salt export protein to the apical membrane in Madin-Darby canine kidney cells.

Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13

Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium.

Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.

Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome.

Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.

P304

e35986

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0035986

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Pecci

P577

2012-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224899521

http://www.w3.org/2001/XMLSchema#string

P698

22558294

http://www.w3.org/2001/XMLSchema#string

P932

3338476

http://www.w3.org/2001/XMLSchema#string